SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8
AMENDMENT TO APPLICATION OR REPORT
Filed pursuant to Section 12, 13 or 15(d) of
THE SECURITIES EXCHANGE ACT OF 1934
HEALTH-CHEM CORPORATION
AMENDMENT NO. 1
The undersigned hereby amends the following items, financial statements,
exhibits or other portions of its Form 8-K Report filed on September 3, 1999 as
set forth below:
Item 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(b) Pro Forma Financial Information
Pro Forma financial information, required to be filed pursuant to Item 7 of
Form 8-K filed on September 3, 1999 reflecting the disposition of substantially
all of the assets of the Company's Herculite Products, Inc. and Hercon
Environmental Corporation subsidiaries is hereby incorporated by reference to
the related Consolidated Financial Statements filed as part of the Company's
Quarterly Report on Form 10-Q for the quarter ended September 30, 1999.
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this amendment to be signed on its behalf by the
undersigned, thereunto duly authorized.
HEALTH-CHEM CORPORATION
By: /s/ Marvin M. Speiser
---------------------
Marvin M. Speiser
President
Date: November 24, 1999
